U.S. Communications Stock News

Curious whether IDEX is attractively priced or trading above its worth? Let’s explore what the numbers and recent market trends reveal about its value proposition. The stock has seen some short-term movement, gaining 1.9% in the last week. It remains down 23.4% over the past year, which may suggest shifting investor sentiment as well as possible opportunities or risks. Recent news related to industry-wide supply chain improvements and IDEX’s ongoing strategic investments has attracted...

In recent days, Meta Platforms announced it is in discussions to purchase billions of dollars' worth of Google's tensor processing units (TPUs) to support its growing artificial intelligence operations, while also securing major legal victories in two high-profile antitrust cases brought by the Federal Trade Commission over the company's market position. Together, these developments highlight Meta's evolving approach to AI hardware sourcing and underscore a period of increased regulatory...

Pitney Bowes (PBI) has launched tender offers to repurchase up to $75 million of its outstanding long-term notes, marking a fresh round of balance sheet management that could catch investors’ attention. The move centers on the company’s 2043 and 2037 notes and comes with clearly defined terms and deadlines. See our latest analysis for Pitney Bowes. After announcing the tender offers, Pitney Bowes has seen momentum build, with a 36.6% year-to-date share price return and a solid 26% total...

Earlier this week, KeyBanc downgraded Kimbell Royalty Partners, LP from 'Overweight' to 'Sector Weight' due to a volatile oil price environment and limited growth prospects in the Permian basin. This downgrade highlights increasing pressure on smaller mineral rights companies as they compete with larger, better-capitalized peers in the acquisition market. We’ll explore how concerns about competition from larger players may influence the investment outlook for Kimbell Royalty Partners. We've...

If you have ever wondered whether Cognex offers real value at today's price, you are not alone. Let's dig into what investors should know before making a move. Despite a 3.3% uptick this week, Cognex’s share price is still down nearly 20% over the past month and has dropped 3.8% in the last year, highlighting how quickly market sentiment can shift. Recent headlines have focused on Cognex’s ongoing expansion into emerging automation markets and new product launches, which are fueling industry...

MongoDB (MDB) is drawing attention as investors look ahead to its upcoming earnings report on December 1. The company’s performance and sustained analyst optimism are both fueling curiosity about its next move. See our latest analysis for MongoDB. MongoDB’s share price has surged over 35% year-to-date, reflecting growing investor confidence as the company’s Atlas cloud platform and enterprise adoption trends gain traction. Despite a modest total shareholder return of just over 3% for the past...

Earlier this week, Hilltop Holdings reported strong earnings with accelerating trends in its broker/dealer segment and stable performance in commercial banking, even as its mortgage segment faced continued challenges. This operational update, alongside recent insider stock sales, signals ongoing shifts within Hilltop’s core businesses and executive activity. To understand the impact of improved broker/dealer trends on Hilltop’s investment outlook, let’s examine how these results reshape the...

Rush Street Interactive (RSI) delivered an impressive third quarter update, reporting a 20% increase in revenue compared to last year. The company also topped expectations and marked its tenth straight quarter of sequential growth. See our latest analysis for Rush Street Interactive. Following RSI’s upbeat third quarter, the stock is building momentum again, with a 1-day share price gain of just over 3% and a year-to-date rise of 34%. While recent volatility saw some pullback last quarter,...

Southwest Gas Holdings (SWX) announced that Justin S. Forsberg will become Chief Financial Officer and Senior Vice President on December 1, following Robert J. Stefani’s departure. This leadership shift brings new finance expertise to the company’s executive team. See our latest analysis for Southwest Gas Holdings. Southwest Gas Holdings’ recent executive moves come as the company’s share price builds momentum, climbing 18.1% year-to-date and closing at $83.05. With renewed leadership, the...

If you’re wondering whether now is a smart time to buy NVIDIA, you’re not alone. Plenty of investors are trying to figure out if the stock’s current price reflects its true value or if there’s an opportunity hiding in plain sight. The past year has seen NVIDIA drive returns of 28.1%, and while the stock is up a strong 28.0% year-to-date, it has experienced a bumpy ride in the last month, sliding 12.8% after a long run-up. Driving the latest swings are headlines spotlighting the ongoing...

Morningstar (MORN) just announced a $1 billion share repurchase program over the next three years, along with new plans to ramp up operational efficiency and data delivery using AI. Both moves signal management’s intent to strengthen long-term value for investors. See our latest analysis for Morningstar. Morningstar’s latest moves come after a stretch of declining momentum, with the share price down 18.1% in the last quarter and the one-year total shareholder return sitting at -38.9%. Despite...

Stride (LRN) is under heavy legal scrutiny as several investor lawsuits allege the company inflated enrollment numbers and overlooked compliance standards. This increased attention has been accompanied by a sharp negative shift in investor sentiment. See our latest analysis for Stride. This string of legal challenges has weighed heavily on Stride’s share price, with a 90-day share price return of -61.07% and a one-year total shareholder return near -41%. Short-term momentum is clearly fading,...

Belden (BDC) is making waves with a slate of new product launches targeting automation and smart infrastructure. The rollout of advanced networking and security solutions signals a strategic push to stay ahead in these rapidly evolving markets. See our latest analysis for Belden. This wave of innovation comes on the heels of a new board appointment and a fresh dividend affirmation, adding some positive news flow. While Belden’s share price has stumbled over the past quarter and year, with a...

Acuity Brands recently reported its fiscal 2025 fourth quarter results, with revenues rising 17.1% year over year to US$1.21 billion, but slightly missing analyst expectations. While the company exceeded EBITDA targets and grew net sales and margins, it missed organic revenue expectations, providing a mix of strong execution and some areas for improvement. To assess how Acuity's missed revenue estimates alongside strong operational gains may reshape its investment story, let’s review the...

In the past week, Privia Health Group reported third-quarter revenue of US$580.4 million, a 32.5% year-over-year increase that topped analyst expectations by 16.6% as it expanded its technology-enabled services across 13 states and the District of Columbia to more than 4.8 million patients. Despite this strong performance, management issued the weakest full-year guidance among peers, leading some investors to question the outlook for the remainder of the year. We'll examine how the contrast...

Citigroup (C) stock has been drawing some extra attention lately as investors analyze recent performance trends and consider the company’s broader position within the banking sector. The bank’s diversified businesses and steady fundamentals often put it on the radar when market sentiment shifts. See our latest analysis for Citigroup. Citigroup’s share price has been gaining real momentum lately, with the stock closing at $103.6. This reflects a 4.5% share price return over the past month and...

Alight, Inc. announced that Rohit Verma, CEO of Crawford & Company, has been appointed as its next Chief Executive Officer and board member effective January 1, 2026, following the departure of Dave Guilmette on December 31, 2025. Verma brings a track record of strategic leadership and operational expertise, including multiple years of record revenue growth and a focus on client centricity, which aligns with Alight’s emphasis on innovation in benefits administration and employee wellbeing...

Crinetics Pharmaceuticals recently announced that the first patient has been randomized in the pivotal Phase 3 CAREFNDR trial, evaluating once-daily, oral paltusotine in adults with carcinoid syndrome due to well-differentiated neuroendocrine tumors. This milestone reflects the company's effort to expand the use of paltusotine, which is already FDA-approved for acromegaly, into an additional patient population with significant unmet medical needs. We'll explore what the advancement of...

US Foods Holding Corp. announced in the past week that its Board of Directors has authorized a share repurchase program of up to US$1 billion. This significant buyback plan reflects management's confidence in the company's outlook and has drawn notable investor attention. Let's explore how the US$1 billion share repurchase could reshape US Foods Holding's investment narrative and market positioning. The end of cancer? These 29 emerging AI stocks are developing tech that will allow early...

Comerica (CMA) shares have edged up modestly over the past week, attracting attention from investors who are curious about the bank’s recent performance and what could be driving the stock’s movement this month. See our latest analysis for Comerica. Comerica’s share price has gained notable ground this year, achieving a 30.8% year-to-date return and a 13.9% increase in the past three months. Its one-year total shareholder return of 16.5% shows positive momentum is building after a stretch of...

Organon (OGN) and Shanghai Henlius just received a green light from the FDA for POHERDY, the first pertuzumab biosimilar approved in the US. This move expands their reach in oncology therapies and opens the door for broader access in treating HER2-positive breast cancer. See our latest analysis for Organon. Organon’s latest FDA win arrives after a year of challenging share price momentum, with a 1-year total shareholder return of -50.17% and a steep year-to-date share price return of -48.46%...

American Healthcare REIT (AHR) just completed a public offering, raising nearly $387 million through the sale of 8.1 million shares of its common stock. This fresh capital is planned for general purposes and future investments, making it a meaningful development for current and prospective shareholders. See our latest analysis for American Healthcare REIT. American Healthcare REIT’s share price has surged recently, with a 1-month return of nearly 14% and an impressive 83% share price return...

Earlier this year, NGL Energy Partners experienced a strong business rebound, highlighted by improved operations and aggressive reductions in debt levels. The water solutions segment, fueled by Delaware Basin drilling, now delivers 85% of EBITDA and supports the company’s stable cash flows. We'll explore how this renewed cash flow strength from water solutions is shaping NGL Energy Partners' overall investment narrative. Outshine the giants: these 25 early-stage AI stocks could fund your...

EchoStar (SATS) shares drew attention after AT&T announced the nationwide deployment of mid-band spectrum acquired from EchoStar. This move focuses on maximizing network potential and monetizing spectrum assets, which matters for investors. See our latest analysis for EchoStar. EchoStar’s rapid appreciation is not just a flash in the pan. Its 18.6% 90-day share price return and eye-catching 222.2% year-to-date gain suggest strong momentum has been building, particularly as the AT&T spectrum...